Insider · CIK 0001709503
Gaetan Michel
Files at VNRX (VOLITIONRX LTD). First filing -, latest -.
Gaetan Michel files SEC Form 4 as COO at VNRX (VOLITIONRX LTD). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gaetan Michel has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -608 | $0.25 | $154 | 12,232 | 13 d ago |
| Oct 4, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -12,333 | $0.65 | $7,992 | 256,746 | Oct 7, 2025 |
| Sep 28, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -11,362 | $0.61 | $6,874 | 369,079 | Sep 30, 2025 |
| Jun 1, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -7,835 | $0.50 | $3,941 | 380,441 | Jun 3, 2025 |
| May 1, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -6,844 | $0.49 | $3,336 | 388,276 | May 5, 2025 |
Questions about Gaetan Michel
Answered from the filings on this page, as of the latest one.
Is Gaetan Michel buying or selling?
Gaetan Michel has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gaetan Michel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gaetan Michel has 0.
Where does Gaetan Michel file Form 4?
Gaetan Michel has filed Form 4 at VNRX (VOLITIONRX LTD) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.